← Open Payments lookup

MIGUEL MOLINA REYNOSO: Open Payments

NPI 1689283384 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,036 in 116 payments from 14 companies in 2025. Trend: 2023 $1,933 · 2024 $1,892 · 2025 $2,036

Food & beverage: $1,931Education: $104
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.16$291
Alkermes, Inc.13$282
Otsuka America Pharmaceutical, Inc.17$248
Neurocrine BioSciences, Inc.11$212
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$164
E.R. Squibb & Sons, L.L.C.11$158
Lundbeck LLC11$155
Janssen Pharmaceuticals, Inc7$149
Indivior Inc.5$111
Vanda Pharmaceuticals Inc.4$109

Products named: REXULTI, INGREZZA, ARISTADA, CAPLYTA, COBENFY, INVEGA SUSTENNA, ABILIFY ASIMTUFII, SUBLOCADE.

Industry payments across FL — which companies pay providers there.